1. Executive Summary (Confidence: High)

Helsinn Healthcare SA, established in 1976, is a third-generation pharmaceutical leader dedicated to the field of supportive care and dermato-oncology.^[1] With 50 years of experience, the group has pioneered an integrated business model that bridges the gap between early-stage innovation and global commercialization.^[1] Headquartered in Lugano, Switzerland, Helsinn maintains direct commercial operations in the United States and high-quality manufacturing in Ireland, reaching patients in over 90 to 140 countries through an extensive network of partners.^[1] The organization is increasingly looking toward the longevity ecosystem by integrating AI-driven drug discovery, as evidenced by its 2026 strategic collaboration with InVirtuoLabs.^[1] Their mission centers on improving the health and quality of life for those battling debilitating chronic conditions.^[4]